Please login to the form below
Cherry
This page shows the latest Cherry news and features for those working in and with pharma, biotech and healthcare.
Sanofi patent case win holds off generic rivals for key cancer drug
The district court found the defendants’ experts cherry-picked data in the references to reach cabazitaxel and were not credible.
Latest news
-
Report shows benefits of GP at Hand digital service, but concerns too
High levels of user satisfaction, but 'cherry picking' concerns remain. A new independent report of Babylon’s GP at Hand ‘digital first’ doctor service has produced plenty of positives for the ... This backs up fears that the service is ‘cherry
-
Babylon expansion sparks ‘NHS destruction’ warnings
The company is accused of 'cherry picking' patients, so that it takes on only the time-poor, relatively healthy patients, and leaves the most complex cases to the existing GP providers.
-
Avenir Global acquires UK communications firm Hanover
based healthcare creative agency Cherry.
-
Crunch time as Brexit deal faces ‘meaningful vote’
of glistening cherries” – alluding to the EU’s assertion at the beginning of negotiations that there would be no opportunity to “cherry pick” the best elements of EU membership.
-
Avenir acquires Cherry, EY wins new account and GK unites businesses
Avenir has strengthened its network of PR and communications functions following the purchase of Cherry, an independent healthcare comms agency. ... Founded in 2005, Cherry has an annual revenue of £9.2m and 80 employees.
More from news
Approximately 1 fully matching, plus 41 partially matching documents found.
Latest Intelligence
-
Creating value from value-based healthcare
If companies try to cherry-pick elements of VBHC that serve their immediate needs without engaging holistically, they will lose credibility and jeopardise their long-term involvement.
-
M&A drivers in healthcare communications
group. For example, Avenir Global, a Canadian holding company, now has a global healthcare operation of around 250 people with the acquisition of Cherry in November 2018.
-
Retaining reader value in plain language summaries of clinical studies
They want to avoid being accused of cherry-picking the secondary endpoints they include or skewing the impression the reader takes away from the PLS.
-
The case for a second Brexit referendum: “We need the informed consent of the people”
However this ‘cherry-picking’ approach has been repeatedly rebuffed by the EU27, and is equally seen as far too soft a Brexit by the likes of Johnson and Rees-Mogg, and
-
Transparency and accountability: tackling opacity and blame head-on
Faceless corporations tainted by past own-goals, profiteering, cherry-picked data and spun claims - so goes the lazy narrative.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest appointments
-
AVENIR GLOBAL appoints global healthcare lead
The AVENIR GLOBAL brands include AXON, Cherry, Hanover, NATIONAL, Padilla and SHIFT.
-
Cognite bolsters creative and account teams
She most recently served as a senior account manager at Cherry Advertising, having first joined the marketing and advertising firm as an account manager in 2013.
-
Health4Brands makes trio of new appointments
Saunders joins H4B London from Frontera, where she was an account manager, and her healthcare advertising career to date also includes a stint at Cherry Advertising.
-
Trevor Aukim joins emotive as head of development
Mootoosamy has over a decade of healthcare communication experience, working with agencies such as Cherry Advertising, CDM London and DDB Health.
-
Claire Hay joins UK creative agency Cherry
Movesto the London agency from PAN Unlimited. London-based creative agency Cherry has appointed Claire Hay as associate director. ... Cherry said Hay would also be tasked with playing a role in the agency's new business efforts and communicating its
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Hunt vs Hawking: We'll call it a draw
For a scientist, there are few greater crimes than misusing statistics and cherry picking evidence. . ... He fought the accusation of cherry picking evidence, by cherry picking more evidence to support his point.
-
European Medical Journal
Address:. The MedBIC. Anglia Ruskin University , Alan Cherry Drive. Chelmsford.
-
Lost for words? Try picturing this… by Mark Spain and Sharon Ombler-Spain
Using technology, people jump between multiple websites, cherry picking particular subjects and dipping into others.
-
Biocair
Address:. Biocair International Limited. The Business Centre , Church End. Cherry Hinton.
-
Cherry Advertising
Cherry Advertising.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- GSK discontinues two feladilimab trials in head and neck cancer
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Live Webinar: Advancing Human Health Through Precise Measures of Movement, Cognition & Biometrics
- Live Webinar: How to Simplify Genetics & Raise Awareness Around Orphan Diseases
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
